Background: Nitrite is a biological factor relevant to oral and systemic homeostasis. Through an oral bacteria reduction process it was suggested that periodontal therapy and chlorhexidine rinse could impact nitrite levels leading to negative effects such as increase in blood pressure. This 6-month randomized clinical trial evaluated the effects of periodontal therapeutic protocols on salivary nitrite and its relation to subgingival bacteria.
Traditional protocols, that are mainly based on quadrant-wise scaling and root planing, have changed little in the past decades. Based on the primary bacterial etiology of both gingivitis and periodontitis, shorter-term protocols that reduce oral environment cross infection 1, 2 as well as protocols enhanced by antimicrobial agents have been tested 3, 4 . Clinical parameters are still considered the gold-standard outcomes when monitoring the results from any periodontal therapy. However, looking for a better understanding of periodontal diseases, microbiological 5 and host-related 6 aspects have been also studied. Nitrite is among them (Figure 1 ). The reversible redox conversion of nitrite and nitric oxide in a physiological setting is now widely accepted 7 . Although nitrite has long been identified as a stable intermediate of nitric oxide oxidation today the reduction of nitrite to nitric oxide in vivo is well supported 7, 8 . Oral bacteria play an important role in nitrite production 9 . Due to nitric oxide highly volatility, in human body fluids such as saliva, its end metabolite nitrite could be used as a nitric oxide synthesis indicator 10, 11 . Nitrite changes could interfere with heart function 12 and blood pressure 13 . Nitrite also correlates to periodontal status, showing increased levels in diseased individuals 14 . During periodontal diseases development, human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines 15 . In addition, it was demonstrated 8 that dental plaque mediates denitrification of nitrate in active concentrations which may locally affect blood flow and signaling between nerves and inflammatory processes in the periodontal tissues.
Chlorhexidine (CHX) and essential oils are antimicrobials commonly used as mouthwashes in periodontal routines 2, 16, 17 , although mechanical procedures alone can also cause microbial changes 18 . After evaluating a healthy population for two weeks, Kapil et al. 19 reported that a reduction in oral nitrate-reducing bacteria following the use of (CHX) significantly affected nitrite concentrations in saliva, which was accompanied by an increase in blood pressure. However, these authors 19 assumed bacterial reductions based on the wide literature about CHX 17, 20 because they did not conduct microbial analysis. As such, readers could not confirm whether these expected reductions really happened in their study population. In addition, considering the influence of periodontal status on oral microbial counts in a healthy population, as in that study, bacterial reductions could be discrete.
In comparison to quadrant scaling, the protocol proposed by Quirynen et al. 21 allows more evident disruptions in oral microbial communities and could be accompanied by systemic findings such higher body temperature. But these findings seem to be transient. More recently, studies have demonstrated that clinical improvements not always are associated with microbial reductions 22, 23 , bringing up the question of how long microbial reductions are kept after periodontal therapy.
Considering that Kapil et al. 19 did not measure bacterial reductions in 2013, it is plausible to inquire as to whether other biological pathways could be responsible for nitrite reduction and the observed higher blood pressure. We also need to keep in mind that the relation between nitric oxide and vasodilatation typically involves Larginine metabolism 24 while bacteria involvement has been less investigated 25 . In gingivitis and periodontitis volunteers, our group had a reduction in salivary arginase activity and periodontal pathogens after therapy 26 ( Figure 1 ).
Based on the above-mentioned literature, it was hypothesized that periodontal treatment would be followed by a reduction of nitrite levels in saliva, which could be related to oral microbial improvements. Therefore, this study was designed with the primary aim of longitudinally evaluating the effects of different periodontal therapeutic protocols on the salivary levels of nitrite and its relation to total subgingival bacterial load and target periodontal pathogens levels.
MATERIALS AND METHODS
The present 6-month, double-blind, single-centered, randomized, parallel group, placebo-controlled clinical trial was approved by the Committee on Research of the University of Taubate (protocol # 521/10), São Paulo, Brazil. All individuals provided written informed consent before enrolling in the present study, which was composed of baseline, 3-, and 6-month post-treatment appointments. The present study was registered at Clinicaltrials.gov (NCT02215460).
Study Population
The study population was composed of mild to moderate chronic periodontitis patients registered in the periodontal screening program of the University of Taubate, Dental School from August 2013 to January 2014. Participants of both genders, 18 years or older, having at least 20 natural teeth, good general health, and chronic periodontitis 27 were recruited by convenience. Specifically, patients had to show at least four teeth with one or more sites with PD ≥ 4 mm and CAL ≥ 3 mm 28 . Exclusion criteria comprised: systemic diseases or other conditions that could influence the periodontal status; events of high blood pressure or diagnosed hypertension; alcohol abuse; orthodontic devices, extended prosthetic fixed devices, removable partial dentures or overhanging restorations; pregnancy or breast-feeding; history of sensitivity or suspected allergies following the use of oral hygiene products; the need for antibiotic prophylaxis; antibiotics and/or anti-inflammatory drug use in the six months prior to the beginning of the study; regular use of chemotherapeutic antiplaque/antigingivitis products; any furcation lesions; periodontal treatment performed within six months prior to study initiation; and unwillingness to return for follow-up.
Salivary nitrite concentration was the outcome considered to calculate the sample size. Based on a previous study 29 (mean and standard deviation values were 15.79 ± 5.59 for advanced periodontitis and 7.78 ± 3.02 for moderate periodontitis) a minimum of 12 patients per group was determined to detect a significant betweengroups effect ranging from 12 to 18% (α = 95%). Considering up to 20% of dropouts during 6 months of follow-up the initial sample size was defined as at least 15 patients per group.
Clinical Periodontal Examinations
Participants underwent a complete periodontal examination during the screening phase to determine periodontal diagnosis, a baseline examination, 3 and 6-months of follow-up after periodontal treatment. Panoramic radiographs were taken in the first periodontal examination 27 . Probing depth (PD), clinical attachment level (CAL), plaque index (PI) 30 , and gingival index (GI) 31 measurements were taken from six periodontal sites, of all teeth, except for the third molars, with a manual periodontal probe k by a single-blinded and calibrated examiner (JRC). After 7 days and one week prior 6-month measurements, periodontal examinations of 10 subjects were repeated showing intra and inter-examiners reproducibility scores higher than 0.85 (Kappa Test) for probing depth (PD) and clinical attachment level (CAL). Intra-class correlation test showed scores higher than 0.90.
Normalization Period
Prior to randomization, selected periodontitis patients were enrolled in a 1-month oral hygiene normalization period. During this month, a trained researcher (SCC) gave patients oral hygiene instructions, fluoride toothpaste ¶ , dental floss # , and a regular toothbrush # . For the study's duration oral hygiene supplies were bimonthly provided.
Periodontal Treatment
Patients were randomly allocated to one of the six treatment groups by a closed envelope system. Opaque envelopes containing identifications for treatment groups were closed, mixed, and then numbered. Each participant took a single envelope, was assigned by a researcher (FOC) to a specific group and attended to clinical appointments in selected days according to type of rinse (CHX, placebo or no-rinse) and type of scaling. According to the designated group, participants receive either conventional quadrant scaling 1 in four weekly sections (QS) or full-mouth scaling within 24 hours (FMS), as proposed by Quirynen et al. 1 . More specifically, (1) quadrant scaling and root planing plus chlorhexidine (QS+CHX); (2) quadrant scaling and root planing plus placebo (QS+Placebo); (3) quadrant scaling and root planing without mouth rinse (QS+None); (4) full-mouth scaling and root planning plus CHX (FMS+CHX); (5) full-mouth scaling and root planning plus placebo (FMS+Placebo); and (6) full-mouth scaling and root planning without mouth rinse (FMS+None).
Two experienced trained periodontists carried out debridement procedures of both protocols with manual Gracey and McCall curettes and Hirschfield files. For QS+CHX, QS+Placebo, FMS+CHX, and FMS+Placebo groups, in the beginning of each session, individuals rinsed 20ml of 0.12% CHX ¶ or placebo solution (Sorbitol solution 15%; ethanol USP 11.6%; sodium saccharin 0.05%; glycerin; mint flavoring; dye blue; and water enough for 1L) for 30 seconds (the last 10 seconds were of gargling), and at the end of each session there was tongue brushing for 1 minute with CHX gel (1% digluconate chlorhexidine, oral gel basis for 30g, sodium saccharin 0.05%, mint flavoring) or placebo gel (oral gel basis for 30g, sodium saccharin 0.05%, mint flavoring) and an additional rinse. Patients were instructed to rinse at home twice a day for 60 consecutive days 1 .
Sampling for Microbial Analysis
Subgingival samples were collected, as previously described by our group 32 . Then, removal paper points were immediately inserted in a minitube and kept on ice. The bacterial cells were dispersed using a vortex mixer at maximum speed for one minute, and the resulting bacterial suspension was stored in a freezer at -80°C until laboratorial processing.
Genomic DNA (gDNA) was extracted and purified from the pellet using a commercial Genomic DNA Mini Kit according to manufacturer's specifications. The absolute quantification of the target organisms was determined by plotting the cycle threshold (Ct) value obtained from each clinical sample against a standard curve generated with known concentrations of reference bacterial strains' gDNA (Table 1) in 10-fold serial dilutions (10 2 -10 7 cells). A negative control (purified PCR-grade water instead of the DNA template) was included in all PCR reactions.
Sampling for Saliva Analysis
Saliva samples were collected in the morning, from 8:00 to 11:00. Patients were instructed not to eat or drink prior to sampling. Immediately before sampling, individuals rinsed their mouths with water. During collection, they remained seated with their heads tilted forward (approximately 45°) and 2.0 mL of unstimulated, whole saliva were collected into sterile Falcon tubes. Samples were centrifuged for 10 min at 15,000×g at 4°C, and the supernatants were immediately stored at −80°C.
Nitrite Determination
The Griess reagent was prepared by mixing 3.86 mmol/L of naphthylethylenediamine dihydrochloride with 58.07 of mmol/L sulfanilamide in 5% phosphoric acid at a proportion of 1:1 33 . A volume of 40 µl salivary samples diluted with ultrapure water between 4 to 20 times were incubated with 40 µl of Griess reagent for 15 minutes at room temperature 33 . The absorbances were measured at 540 nm using a microplate reader. A standard curve was generated with sodium nitrite in concentrations ranging from 2 to 100 µmol/L. The protein concentration in the diluted saliva samples ranged from 0.02 and 0.52 mg/mL, which is far below the values found in desproteinization samples by ultrafiltration (6 mg/mL) accepted to determine nitrite with Griess reagent 34 .
All sampling and laboratorial procedures were performed by personnel (SCC, ER) blinded to periodontal treatment group.
Statistical Analysis
The primary outcome was the change in mean levels of nitrite. These levels were compared over time using Friedman and ANOVA (Analysis of Variance) or MannWhitney tests 35 . The Spearman correlation test 35 was used to evaluate the relation between nitrite and other variables. Mann-Whitney and Kruskal-Wallis were used to compare clinical data at baseline while Chi-Square test was used to compare sex and gender. To verify the influence of diseased periodontal sites on nitrite an additional analysis took into consideration the percentage of sites showing PD > 4mm and CAL>3mm. In the presence of a significant influence of a given factor, a multiple comparisons test (Least Significant Difference) was applied. Yes. Data was corrected using Kolmogorov-Smirnov (normality of residual values) and Levene tests (constancy of variances). The Friedman test was used for comparisons among evaluation times (baseline, 3, and 6 months) regarding the total bacterial load. When appropriate 35 , Kruskal-Wallis was used instead of ANOVA to analyze the levels of bacterial species separate or considering P. gingivalis, T. denticola and T. forsythia as the consortium named "red complex" 36 . Normality of all variables was tested through Kolmogorov-smirnov test with Liliefors correction.
The results were statistically significant when p < 0.05 and the software used was SPSS 14.0 for windows † † ..
RESULTS
Out of 90 randomized individuals, 84 completed the study, 41 in the QS group and 43 in the FMS group (Figure 2 ). There was a higher percentage (p < 0.05) of females in both, QS (61.1%) and FMS (68.6%) groups. Also, the number of never smokers was higher (p < 0.05) in the QS (61.1%) and FMS (51.4%) groups, when compared to current and past smokers. In the QS group, two patients who rinsed with chlorhexidine experienced teeth staining and decided not to continue in the study. Although some volunteers in the FMS group who rinsed with chlorhexidine reported adverse events, this was not a reason to drop out of the study. All other follow-up failures also occurred before the 3-month examination and were classified as withdrawn by subject.
Treatments were efficient in terms of CAL, PD, PI and GI reductions (Table 1) . There were no differences among groups for any of the clinical variables at any time point.
Except for individuals in the FMS group who rinsed using the placebo, the mean values of salivary nitrite remained statistically unchanged overtime (Table 2) . Therefore, the 60-day use of CHX was not followed by changes in nitrite concentrations in saliva.
In general, there was no significant correlation between nitrite and CAL. Similar findings were observed when the relation between nitrite and PD was tested in each separate group. However, when the rinse type was not considered, at 3 and 6 months a higher percentage of periodontal sites showing PD>4mm was correlated with a reduced concentration of nitrite in saliva among individuals treated by full-mouth scaling ( Table 3 ).
The relation between nitrite and microbiological parameters was tested. The number of significant correlations was not high. When treatment groups were considered isolate, most significant correlations were negative and observed when placebo or non-rinse was used. In CHX groups, there were only two significant correlations. The first was negative, involving the total bacterial load and occurring at 6 months, possibly under the residual influence of periodontal treatment (FMS + CHX group, Table 4 ). On the other hand, the second correlation involved P. gingivalis, but was found at baseline and was positive, showing no effect by periodontal treatment (QS + CHX group, Table 4 ). In fact, most significant correlations were observed when rinses were not taken into consideration (QS vs. FMS). This last analysis revealed some negative correlations between nitrite and microbial parameters, mainly in the FMS group at both 3 and 6 months ( Table 4 ). The type of scaling exhibited a greater influence on nitrite concentrations than CHX rinse.
DISCUSSION
In 2013, Kapil et al. 19 conducted an interesting study in which volunteers with a health periodontium rinsed with chlorhexidine solution for 7 days to suppress the oral microbiota and then the authors measured oral and systemic nitrite levels and blood pressure. Our group designed the present study to expand upon their findings by including additional bacterial data. Human nitrate reduction is highly dependent on the oral commensal bacteria because human cells do not convert nitrate to nitrite to a high degree. Since nitrate is inert in the human body, unless it is activated and reduced by bacteria, simply sampling salivary nitrate would not be useful 10, 11 . It has to first be converted to nitrite to have any biological activity. Salivary nitrate is metabolized to nitrite via a two-electron reduction by nitrate reductases produced by facultative and obligate anaerobic commensal oral bacteria 8, 9 .
We selected periodontally diseased volunteers, sampled dental biofilm, determined bacterial levels, and used CHX for a longer time period. In Kapil et al.'s 15 study the greatest nitrite reduction that followed CHX use was found in oral levels (a 90% reduction). For this reason, in the present study nitrite levels were monitored in saliva. Mean baseline values observed in the present study were similar to that reported by Poorsattar Bejeh-Mir 38 for periodontitis patients. However, the present mean values tended to remain statistically unchanged over time (Table 2) . Overall, this finding indicates no influence of mouth rinse on salivary nitrite. It is important to mention that Kapil et al. 19 investigated a 7-day period of CHX rinse without any periodontal intervention while in the present study, CHX was rinsed for 60 days and was prescribed as part of two treatment schemes. Maybe the observed nitrite changes reported by Kapil et al. 19 have a transient pattern that is not sustained as CHX was used for a longer time period. Shorter post-therapy evaluation times could represent both a limitation of the present study and an opportunity for further investigations. Similarly, to reach a better understanding about nitrite and periodontal therapy different oral antiseptics should be tested. In addition, although those authors assumed microbial reductions, they did not measure bacterial levels in their study as we did not measure blood pressure. Although in the present study hypertensive periodontitis patients were not selected this is a limitation that should be handled in the future. Further, the fact that the present study analyzed a convenience sample impacts findings' external validity. It is important to keep in mind that healthy volunteers have lower frequencies 39 , lower levels 40 , and different profiles 41 of bacteria than periodontally diseased individuals. Therefore, although bacterial reductions were expected, we cannot evaluate to what degree their volunteers 19 experienced these changes. But unfortunately, based on their 19 and the present studies, it would be a mere speculation to suggest that other mechanisms were responsible for the reduction in oral and circulating nitrite levels and increase in blood pressure. As suggested by Bryan 11 , it is not clear weather salivary nitrite reflects the levels of circulating nitric oxide. Therefore, additional nitrite research is required to investigate its role as a plausible link between oral and systemic health. In this context, the involvement of Larginine metabolism in the relation between nitric oxide and vasodilatation has been investigated 24 for a longer time in comparison to the involvement of bacteria 25 . In a population composed of gingivitis and periodontitis volunteers, our group observed a reduction in salivary arginase activity after therapy 26 . Besides clinical improvements, this same population showed a reduction in the frequency of positive samples for target periodontal pathogens 26 . Of course, the role of oral bacteria deserves attention, particularly as part of the link between oral and systemic conditions. Some genus such as Porphyromonas, which includes one bacterial species investigated in the present study, is among the best nitrate-reduction bacterial groups according to Hyde et al. 9 . But the most relevant result from this research group 9 is the marked differences in the potential of nitrate-reduction revealed by bacteria when the six tongue samples collected were compared. Interestingly, Streptococcus was the dominant genus independent of the nitrate-reduction capacity shown by bacterial group 9 . In the present study, S. oralis was positively correlated with nitrite when the type of therapy (FMS) was considered at 3 months, while P. gingivalis was positively correlated with nitrite at baseline in the QS group who rinsed with CHX. When evaluated as a bacterial consortium, typically involved with periodontitis, designated as the "red complex" by Socransky et al. 36 , P. gingivalis, T. forsythia, and T.denticola demonstrated additional correlations to nitrite. In this case, they were negative correlations and tended to occur at 3 months. Considering other salivary biomarkers, mainly matrix metalloproteinase (MMP)-8 and -9, Ramseier et al. 42 reported their combination with "red complex" bacteria provided highly accurate predictions of periodontal disease category. When the correlation between total bacterial load and nitrite was investigated at 6 months, there was a negative correlation in the FMS+CHX group. Then, the number of significant correlations between nitrite and bacterial parameters was not high. In the isolate analysis of treatment groups, most significant correlations were negative and observed when placebo or non-rinse was used. Using a two rotating biological contactor biofilm model, Peng et al. 43 also reported that the microbial community at different locations had distinct patterns regarding nitrite-oxidizing bacteria, highlighting that the potential of subgingival biofilm has not been deeply understood.
Mean values of the clinical attachment level (CAL) were greater at baseline than at 3 and 6 months (Table 1) , supporting the efficacy of the tested therapeutic protocols 44, 45 . Although CAL was not the primary outcome in the present study, any clinical failure could lead us to a misinterpretation about the effects of periodontitis treatment on nitrite concentrations. In general, there was no significant correlation between nitrite and CAL. While some salivary biomarkers, such as interleukin-1β, are associated with CAL 46 others, such as interleukin-2, are not always 47 . In addition, salivary findings could not be in accordance to bacterial findings 48 . These profiles are partially explained by the pattern of periodontitis development that shows periods of activity and periods of quiescence 49 .
Overall, the type of scaling exhibited a greater influence on nitrite concentrations than CHX rinse. Our results suggest a tendency for short-term scaling (FMS). The unique decrease in mean nitrite concentrations was observed among patients treated by FMS who rinsed using the placebo (Table 2 ). Its lower level was sustained throughout the 6 months. In spite of the well-documented placebo effect in medicine 50 , this has not been traditionally investigated in periodontal research. Similarly, we do not know the placebo effect on salivary nitrite concentrations. In addition, when comparisons did not take into consideration the type of rinse (QS vs. FMS), the highest number of significant correlations was observed. At 3 and 6 months, a higher percentage of deeper periodontal pockets (PD > 4mm) was correlated with lower concentrations of nitrite in saliva among individuals treated by FMS (Table 3) . Interestingly, as PD increases the number of bacteria, and particularly, the number of periodontal pathogens (such as P. gingivalis, T. forsythia, T. denticola, and A. actinomycetemcomitans) also increase. This finding suggests an inverse pattern for the present study in comparison to that reported by Kapil et al. 15 , i.e., the reduced number of bacteria was responsible for the lower concentration of nitrite.
Finally, in the FMS group, nitrite was negatively correlated with total bacterial load and levels of A. actinomycetemcomitans at 6 months and at both post-treatment examinations with T. forsythia, T. denticola, and the "red complex" bacterial consortium ( Table 4 ).
Considering that sampling saliva is simple and noninvasive and that salivary nitrite is an important biomarker it seems rationale to use salivary nitrite as a clinical test. On the other hand, although, Poorsattar Bejeh-Mir X reported promising results revealed by good sensitivity (0.93), specificity (0.96), positive (0.93) and negative (0.96) predictive values for salivary nitrite, unfortunately, it seems premature to determine its clinical relevance when monitoring periodontal patients.
CONCLUSIONS
The nitrite concentration in saliva was slightly impacted by periodontitis treatment. The relation between nitrite and bacterial levels after periodontitis treatment appears weak. In periodontitis patients, short-term scaling exhibited a greater influence on nitrite concentrations then the long-term use of CHX rinse. Different capital letters within lines indicate significant differences overtime while different lower-case letters within columns indicate significant differences between groups
In the first set of comparisons the study population is grouped by type of rinse (chlorhexidine, placebo or none) and type of scaling and root planing (quadrant or full-mouth); while in the second set of analysis only the type of scaling was considered. In the first set of comparisons the study population is grouped by type of rinse (chlorhexidine, placebo or none) and type of scaling and root planing (quadrant or full-mouth); while in the second set only the type of scaling was considered. 
